Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology-Reference-Cited by-同舟云学术

Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology

Published:2015-10-12 Issue:3 Volume:124 Page:181-187
ISSN:1934-662X
Container-title:Cancer Cytopathology
language:en
Short-container-title:Cancer Cytopathology

Author:

Faquin William C.¹,Wong Lawrence Q.²,Afrogheh Amir H.¹,Ali Syed Z.³,Bishop Justin A.³,Bongiovanni Massimo⁴,Pusztaszeri Marc P.⁵,VandenBussche Christopher J.³,Gourmaud Jolanta⁴,Vaickus Louis J.¹,Baloch Zubair W.²

Affiliation:

1. Massachusetts General Hospital; Boston Massachusetts

2. Hospital of the University of Pennsylvania; Philadelphia Pennsylvania

3. Johns Hopkins Hospital; Baltimore Maryland

4. Institute of Pathology; University Hospital; Lausanne Switzerland

5. Geneva University Hospitals; Geneva Switzerland

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference35 articles.

1. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer;Cooper;Thyroid.,2009